Showing 501-510 of 796 results for "".
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/the-latest-on-systemic-agents-for-psoriasis/29073/The pharmacologic pipeline continues to produce strong options for systemic treatment of psoriasis. Practical Dermatology® spoke with Editorial Board member Jashin J. Wu, MD, FAAD, Founder and CEO of the Dermatology Research and Education Foundation, to discuss the latest treatment considerations wiCheckpoint Blockade for Advanced cSCC: Exploring Newer Options
https://practicaldermatology.com/topics/skin-cancer-photoprotection/checkpoint-blockade-for-advanced-cscc-exploring-newer-options/23487/Two newer systemic options on the market provide hope in the fight against advanced cutaneous squamous cell carcinoma.Is Your Advisor Working in Your Best Interest?
https://practicaldermatology.com/topics/practice-management/is-your-advisor-working-in-your-best-interest/20361/Understanding fiduciary versus suitability standards.Currents: Psoriasis
https://practicaldermatology.com/topics/psoriasis/currents-psoriasis/20438/Save Us
https://practicaldermatology.com/topics/skin-cancer-photoprotection/save-us/20452/New Products Therapeutics Focus: Sports Dermatoses
https://practicaldermatology.com/columns/new-products/new-products-therapeutics-focus-sports-dermatoses/21153/New products and pharmacologic developmentsCurrents
https://practicaldermatology.com/topics/general-topics/currents/21175/Dermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0909_05-php/22769/Update on Atopic Dermatitis 2018
https://practicaldermatology.com/topics/general-topics/update-on-atopic-dermatitis-2018/20354/A look at the pathophysiology of AD, including structural and immunologic contributors, as well as new therapeutic developments with an eye toward breakthroughs on the horizon.